About MinapharmMinapharm Pharmaceuticals is a leading pharmaceutical company in Egypt and the Middle East and the largest end-to-end manufacturer of biological therapies in MEA with over 20 years of experience in cellular and bioprocess engineering.Headquartered in Cairo, Minapharm commercializes over 100 life-saving and life-enhancing products ranging from small molecules to complex bioengineered proteins and viral vectors, with an impressive immunotherapy pipeline.Together with its wholly-owned Berlin-based subsidiary, ProBioGen AG - a world-leading CDMO, Minapharm has established an integrated business model making it the only gene-to-market company in the region.Consolidating its international platform of intelligent biopharmaceutical technologies with the longstanding process development and manufacturing expertise in the MEA, Minapharm, together with ProBioGen, has incorporated MiGenTra GmbH headquartered in Berlin and manufacturing in Cairo, to enhance the accessibility to critical healthcare transforming medicines through product development and commercialization of Biosimilar mABs, Cell, and Gene Therapies and vaccines, at affordable prices in Egypt, and MEA.Minapharm employs a collective workforce of over than 1400 individuals & continues to expand their workforce with talented pool of Human Capital.Our Core Values:Diversity & RespectIntegrity & AccountabilityCollaborationLeadership & EmpowermentInnovation & Continuous LearningJob SummaryExecute financial audit engagements with independence and technical rigor, prepare evidence-based working papers and draft reports.واجبات الوظيفةContribute to the preparation of the financial audit work programs; propose audit procedures and testing approaches based on risk assessment outcomes.Prepare the information and document request lists required for each financial audit engagement before fieldwork commences.Execute financial audit fieldwork independently across assigned areas (payroll, AP/AR, fixed assets, treasury, tax, financial reporting), applying approved audit procedures with rigor and objectivity.Identify and document control deficiencies, financial irregularities, and compliance gaps; link findings to risk implications and applicable standards (IIA, IFRS/IAS, Egyptian Accounting Standards, Tax Law).Prepare Corrective/Preventive Action Requests (CPAR) when control weaknesses or non-conformities are identified during fieldwork.Supervise and guide junior auditors during financial audit engagements; review their working papers, provide technical feedback, and ensure quality of work before submission to the Deputy Manager.Prepare well-structured draft financial audit reports including findings, root causes, risk ratings, and practical recommendations; submit to Deputy Manager for reviewParticipate in closing meetings with auditee management; present and defend audit findings professionally.Conduct follow-up reviews of agreed corrective actions from prior financial audit engagements; document findings and escalate unresolved items to Deputy Manager.Maintain organized, complete, and retrievable working paper files for all financial audit engagements in accordance with the department's filing standards.Carry out any other tasks assigned by the direct supervisor that fall within the scope of the role.RequirementsBachelor's degree in Accounting, Finance, or a related field.CIA is preferred. CPA, CMA, or progress toward these certifications is an advantage.Minimum 2–6 years in internal or external audit with a financial focus; prior experience supervising junior staff is an advantage.Good knowledge of IIA Standards, IFRS/IAS, Egyptian Accounting Standards, Egyptian Tax Law, and internal control frameworks (COSO).Strong analytical skills, professional skepticism, attention to detail, structured report writing, and ability to coach junior auditors.Proficiency in Arabic and English (written and spoken).
Minapharm Pharmaceuticals is an Egyptian pharmaceutical company manufacturing and marketing prescription medicines across therapeutic areas including immunology, oncology, neuroscience, and infectious disease. The company also operates biotechnology research and contract manufacturing services.
What you should know
Comprehensive Bioengineered Medicines: Employs over 1,400 people and manages a product portfolio of life-saving medicines ranging from small molecules to complex bioengineered proteins
Biotech Powerhouse: Operates as a leader in regional biotechnology through its German subsidiary ProBioGen, providing advanced cell line development and genetic engineering
Phase 1 Approval: Achieved a significant milestone in 2023 by receiving regulatory approval from Germany's Paul-Ehrlich Institute for a phase 1 clinical trial of its Adalimumab biosimilar